nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—prostate gland—prostate cancer	0.0099	0.16	CbGeAlD
Gabapentin—CACNA2D1—prostate gland—prostate cancer	0.00653	0.105	CbGeAlD
Gabapentin—CACNA1B—testis—prostate cancer	0.00555	0.0894	CbGeAlD
Gabapentin—BCAT1—testis—prostate cancer	0.00436	0.0703	CbGeAlD
Gabapentin—ADORA1—renal system—prostate cancer	0.00429	0.0692	CbGeAlD
Gabapentin—ADORA1—urethra—prostate cancer	0.00422	0.068	CbGeAlD
Gabapentin—CACNA1B—lymph node—prostate cancer	0.00402	0.0648	CbGeAlD
Gabapentin—CACNA2D2—testis—prostate cancer	0.004	0.0645	CbGeAlD
Gabapentin—CACNA2D1—bone marrow—prostate cancer	0.00337	0.0542	CbGeAlD
Gabapentin—BCAT1—lymph node—prostate cancer	0.00316	0.051	CbGeAlD
Gabapentin—CACNA2D2—lymph node—prostate cancer	0.0029	0.0467	CbGeAlD
Gabapentin—CACNA2D1—testis—prostate cancer	0.00288	0.0464	CbGeAlD
Gabapentin—ADORA1—testis—prostate cancer	0.00278	0.0447	CbGeAlD
Gabapentin—CACNA2D1—lymph node—prostate cancer	0.00209	0.0336	CbGeAlD
Gabapentin—ADORA1—lymph node—prostate cancer	0.00201	0.0324	CbGeAlD
Gabapentin—ADORA1—GPCR downstream signaling—VIP—prostate cancer	0.000161	0.000834	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNRH1—prostate cancer	0.000161	0.000834	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC5A5—prostate cancer	0.000161	0.00083	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—ADRB2—prostate cancer	0.00016	0.000825	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RLN2—prostate cancer	0.000158	0.000816	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA4—prostate cancer	0.000157	0.000811	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TBXAS1—prostate cancer	0.000157	0.000811	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP2E1—prostate cancer	0.000157	0.000811	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GRP—prostate cancer	0.000156	0.000807	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—LPAR1—prostate cancer	0.000156	0.000807	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NQO1—prostate cancer	0.000155	0.000801	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PLCB2—prostate cancer	0.000155	0.000799	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA2—prostate cancer	0.000153	0.00079	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TH—prostate cancer	0.000153	0.00079	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP3A4—prostate cancer	0.000151	0.000782	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SULT1A1—prostate cancer	0.000151	0.00078	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCG5—prostate cancer	0.000151	0.00078	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTBP2—prostate cancer	0.000151	0.000779	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HSD17B1—prostate cancer	0.000151	0.000779	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1B1—prostate cancer	0.000149	0.000768	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PDE4D—prostate cancer	0.000148	0.000762	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTA1—prostate cancer	0.000148	0.000762	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNRH1—prostate cancer	0.000147	0.000757	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—VIP—prostate cancer	0.000147	0.000757	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTO1—prostate cancer	0.000146	0.000754	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD3B2—prostate cancer	0.000146	0.000754	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NAT2—prostate cancer	0.000146	0.000754	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLXNB1—prostate cancer	0.000145	0.000746	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GGT1—prostate cancer	0.000144	0.000744	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GRP—prostate cancer	0.000142	0.000733	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—LPAR1—prostate cancer	0.000142	0.000733	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NCOA1—prostate cancer	0.000142	0.000733	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PLCB2—prostate cancer	0.000141	0.000726	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNG5—prostate cancer	0.00014	0.000725	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLCB2—prostate cancer	0.00014	0.000722	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LRP2—prostate cancer	0.00014	0.000722	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2C18—prostate cancer	0.00014	0.000722	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP19A1—prostate cancer	0.00014	0.000722	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRPR—prostate cancer	0.000139	0.000718	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CX3CL1—prostate cancer	0.000138	0.000712	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—P4HB—prostate cancer	0.000137	0.000708	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—RXRA—prostate cancer	0.000135	0.000697	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL17RD—prostate cancer	0.000134	0.000694	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PDE4D—prostate cancer	0.000134	0.000692	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC22A1—prostate cancer	0.000133	0.000689	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SULT2A1—prostate cancer	0.00013	0.000672	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—COMT—prostate cancer	0.00013	0.000672	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—prostate cancer	0.00013	0.00067	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTP1—prostate cancer	0.000129	0.000668	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MED12—prostate cancer	0.000128	0.000661	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GNG5—prostate cancer	0.000128	0.000658	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—prostate cancer	0.000127	0.000658	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ITPR1—prostate cancer	0.000127	0.000658	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNG5—prostate cancer	0.000127	0.000656	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—EP300—prostate cancer	0.000124	0.000639	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PTHLH—prostate cancer	0.000122	0.000632	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA3—prostate cancer	0.000122	0.000631	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TYMS—prostate cancer	0.00012	0.000621	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—WNT4—prostate cancer	0.00012	0.000618	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUP—prostate cancer	0.00012	0.000618	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—prostate cancer	0.000119	0.000614	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPL—prostate cancer	0.000117	0.000603	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HPGDS—prostate cancer	0.000117	0.000602	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2C19—prostate cancer	0.000116	0.000599	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ANXA1—prostate cancer	0.000115	0.000594	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RALBP1—prostate cancer	0.000114	0.00059	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MC2R—prostate cancer	0.000114	0.00059	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—prostate cancer	0.000113	0.000584	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ACHE—prostate cancer	0.000113	0.000584	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1A1—prostate cancer	0.000113	0.000582	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2A6—prostate cancer	0.000112	0.000578	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ERCC2—prostate cancer	0.000112	0.000578	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTHLH—prostate cancer	0.000111	0.000574	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKR1C3—prostate cancer	0.000109	0.000562	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKACB—prostate cancer	0.000109	0.000561	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PRKACB—prostate cancer	0.000108	0.000559	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CALCA—prostate cancer	0.000108	0.000556	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP17A1—prostate cancer	0.000107	0.000553	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPP3CA—prostate cancer	0.000106	0.000547	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL12—prostate cancer	0.000105	0.000543	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—prostate cancer	0.000105	0.000543	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ANXA1—prostate cancer	0.000104	0.000539	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARA—prostate cancer	0.000103	0.000533	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA2—prostate cancer	0.000102	0.000527	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PENK—prostate cancer	0.000102	0.000526	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000101	0.000523	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CALCA—prostate cancer	9.78e-05	0.000505	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC5A5—prostate cancer	9.74e-05	0.000503	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GHR—prostate cancer	9.72e-05	0.000502	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAV1—prostate cancer	9.7e-05	0.000501	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCQ—prostate cancer	9.6e-05	0.000496	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL12—prostate cancer	9.55e-05	0.000493	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2E1—prostate cancer	9.51e-05	0.000491	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NQO1—prostate cancer	9.41e-05	0.000486	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRP1—prostate cancer	9.32e-05	0.000481	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TH—prostate cancer	9.27e-05	0.000479	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP3A4—prostate cancer	9.17e-05	0.000474	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB2—prostate cancer	9.03e-05	0.000466	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1B1—prostate cancer	9.02e-05	0.000466	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—prostate cancer	8.86e-05	0.000457	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—prostate cancer	8.83e-05	0.000456	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—VAV3—prostate cancer	8.8e-05	0.000454	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GGT1—prostate cancer	8.73e-05	0.000451	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCQ—prostate cancer	8.72e-05	0.00045	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VIP—prostate cancer	8.66e-05	0.000447	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNRH1—prostate cancer	8.66e-05	0.000447	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA1—prostate cancer	8.6e-05	0.000444	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ITPR1—prostate cancer	8.54e-05	0.000441	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP19A1—prostate cancer	8.48e-05	0.000438	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPAR1—prostate cancer	8.39e-05	0.000433	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRP—prostate cancer	8.39e-05	0.000433	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—INS—prostate cancer	8.36e-05	0.000432	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLCB2—prostate cancer	8.3e-05	0.000429	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LRP2—prostate cancer	8.3e-05	0.000429	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB2—prostate cancer	8.2e-05	0.000423	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CREBBP—prostate cancer	8.19e-05	0.000423	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—RXRA—prostate cancer	8.18e-05	0.000422	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CX3CL1—prostate cancer	8.14e-05	0.00042	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—P4HB—prostate cancer	8.14e-05	0.00042	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—prostate cancer	8.11e-05	0.000419	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—VAV3—prostate cancer	7.99e-05	0.000413	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIST1H2BG—prostate cancer	7.99e-05	0.000413	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDE4D—prostate cancer	7.92e-05	0.000409	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GRB7—prostate cancer	7.92e-05	0.000409	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—COMT—prostate cancer	7.88e-05	0.000407	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—prostate cancer	7.84e-05	0.000405	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CD—prostate cancer	7.77e-05	0.000401	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ITPR1—prostate cancer	7.75e-05	0.0004	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIST1H4H—prostate cancer	7.72e-05	0.000399	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ITPR1—prostate cancer	7.72e-05	0.000399	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—prostate cancer	7.71e-05	0.000398	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNG5—prostate cancer	7.53e-05	0.000389	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—prostate cancer	7.33e-05	0.000379	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TYMS—prostate cancer	7.29e-05	0.000377	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—prostate cancer	7.21e-05	0.000372	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPL—prostate cancer	7.08e-05	0.000365	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP1A1—prostate cancer	6.83e-05	0.000353	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ERCC2—prostate cancer	6.78e-05	0.00035	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—prostate cancer	6.77e-05	0.00035	CbGpPWpGaD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.73e-05	9.04e-05	CcSEcCtD
Gabapentin—Dyspnoea—Docetaxel—prostate cancer	6.71e-05	9.02e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PTGS2—prostate cancer	6.71e-05	0.000346	CbGpPWpGaD
Gabapentin—Somnolence—Docetaxel—prostate cancer	6.7e-05	9e-05	CcSEcCtD
Gabapentin—Discomfort—Prednisone—prostate cancer	6.69e-05	8.99e-05	CcSEcCtD
Gabapentin—Eye disorder—Epirubicin—prostate cancer	6.68e-05	8.98e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Etoposide—prostate cancer	6.68e-05	8.97e-05	CcSEcCtD
Gabapentin—Tinnitus—Epirubicin—prostate cancer	6.67e-05	8.96e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.64e-05	8.93e-05	CcSEcCtD
Gabapentin—Cardiac disorder—Epirubicin—prostate cancer	6.64e-05	8.92e-05	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—prostate cancer	6.63e-05	8.91e-05	CcSEcCtD
Gabapentin—Dyspepsia—Docetaxel—prostate cancer	6.63e-05	8.91e-05	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—prostate cancer	6.62e-05	8.89e-05	CcSEcCtD
Gabapentin—Hepatitis—Doxorubicin—prostate cancer	6.62e-05	8.89e-05	CcSEcCtD
Gabapentin—Insomnia—Capecitabine—prostate cancer	6.59e-05	8.86e-05	CcSEcCtD
Gabapentin—Hypoaesthesia—Doxorubicin—prostate cancer	6.58e-05	8.84e-05	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—prostate cancer	6.57e-05	8.82e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TGFBR1—prostate cancer	6.56e-05	0.000339	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTHLH—prostate cancer	6.56e-05	0.000339	CbGpPWpGaD
Gabapentin—Paraesthesia—Capecitabine—prostate cancer	6.55e-05	8.8e-05	CcSEcCtD
Gabapentin—Decreased appetite—Docetaxel—prostate cancer	6.55e-05	8.8e-05	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—prostate cancer	6.53e-05	8.78e-05	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—prostate cancer	6.52e-05	8.76e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Docetaxel—prostate cancer	6.5e-05	8.74e-05	CcSEcCtD
Gabapentin—Asthenia—Etoposide—prostate cancer	6.5e-05	8.74e-05	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—prostate cancer	6.5e-05	8.73e-05	CcSEcCtD
Gabapentin—Dyspnoea—Capecitabine—prostate cancer	6.5e-05	8.73e-05	CcSEcCtD
Gabapentin—Oedema—Prednisone—prostate cancer	6.49e-05	8.73e-05	CcSEcCtD
Gabapentin—Anaphylactic shock—Prednisone—prostate cancer	6.49e-05	8.73e-05	CcSEcCtD
Gabapentin—Fatigue—Docetaxel—prostate cancer	6.49e-05	8.72e-05	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—prostate cancer	6.49e-05	8.71e-05	CcSEcCtD
Gabapentin—Nausea—Mitoxantrone—prostate cancer	6.47e-05	8.69e-05	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—prostate cancer	6.46e-05	8.68e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—AKR1C3—prostate cancer	6.46e-05	0.000333	CbGpPWpGaD
Gabapentin—Infection—Prednisone—prostate cancer	6.45e-05	8.67e-05	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—prostate cancer	6.44e-05	8.66e-05	CcSEcCtD
Gabapentin—Pain—Docetaxel—prostate cancer	6.44e-05	8.65e-05	CcSEcCtD
Gabapentin—Constipation—Docetaxel—prostate cancer	6.44e-05	8.65e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PRKACB—prostate cancer	6.42e-05	0.000332	CbGpPWpGaD
Gabapentin—Dyspepsia—Capecitabine—prostate cancer	6.42e-05	8.62e-05	CcSEcCtD
Gabapentin—Chills—Epirubicin—prostate cancer	6.42e-05	8.62e-05	CcSEcCtD
Gabapentin—Pruritus—Etoposide—prostate cancer	6.41e-05	8.61e-05	CcSEcCtD
Gabapentin—Shock—Prednisone—prostate cancer	6.39e-05	8.59e-05	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—prostate cancer	6.38e-05	8.57e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—MTHFR—prostate cancer	6.37e-05	0.000329	CbGpPWpGaD
Gabapentin—Nervous system disorder—Prednisone—prostate cancer	6.37e-05	8.56e-05	CcSEcCtD
Gabapentin—Tachycardia—Prednisone—prostate cancer	6.34e-05	8.52e-05	CcSEcCtD
Gabapentin—Decreased appetite—Capecitabine—prostate cancer	6.34e-05	8.52e-05	CcSEcCtD
Gabapentin—Alopecia—Epirubicin—prostate cancer	6.32e-05	8.49e-05	CcSEcCtD
Gabapentin—Skin disorder—Prednisone—prostate cancer	6.31e-05	8.48e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Capecitabine—prostate cancer	6.3e-05	8.46e-05	CcSEcCtD
Gabapentin—Fatigue—Capecitabine—prostate cancer	6.29e-05	8.45e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Prednisone—prostate cancer	6.28e-05	8.44e-05	CcSEcCtD
Gabapentin—Mental disorder—Epirubicin—prostate cancer	6.26e-05	8.42e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PPP3CA—prostate cancer	6.26e-05	0.000323	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—THBS1—prostate cancer	6.26e-05	0.000323	CbGpPWpGaD
Gabapentin—Erythema multiforme—Doxorubicin—prostate cancer	6.26e-05	8.4e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PPARA—prostate cancer	6.25e-05	0.000323	CbGpPWpGaD
Gabapentin—Constipation—Capecitabine—prostate cancer	6.24e-05	8.38e-05	CcSEcCtD
Gabapentin—Pain—Capecitabine—prostate cancer	6.24e-05	8.38e-05	CcSEcCtD
Gabapentin—Erythema—Epirubicin—prostate cancer	6.22e-05	8.36e-05	CcSEcCtD
Gabapentin—Malnutrition—Epirubicin—prostate cancer	6.22e-05	8.36e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Docetaxel—prostate cancer	6.21e-05	8.34e-05	CcSEcCtD
Gabapentin—Diarrhoea—Etoposide—prostate cancer	6.2e-05	8.33e-05	CcSEcCtD
Gabapentin—Anorexia—Prednisone—prostate cancer	6.19e-05	8.32e-05	CcSEcCtD
Gabapentin—Eye disorder—Doxorubicin—prostate cancer	6.18e-05	8.31e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ANXA1—prostate cancer	6.17e-05	0.000319	CbGpPWpGaD
Gabapentin—Tinnitus—Doxorubicin—prostate cancer	6.17e-05	8.29e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Docetaxel—prostate cancer	6.16e-05	8.27e-05	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—prostate cancer	6.14e-05	8.25e-05	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—prostate cancer	6.13e-05	8.24e-05	CcSEcCtD
Gabapentin—Tension—Epirubicin—prostate cancer	6.11e-05	8.21e-05	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—prostate cancer	6.1e-05	8.19e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PRKCZ—prostate cancer	6.06e-05	0.000313	CbGpPWpGaD
Gabapentin—Nervousness—Epirubicin—prostate cancer	6.05e-05	8.12e-05	CcSEcCtD
Gabapentin—Back pain—Epirubicin—prostate cancer	6.02e-05	8.09e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Capecitabine—prostate cancer	6.01e-05	8.07e-05	CcSEcCtD
Gabapentin—Dizziness—Etoposide—prostate cancer	5.99e-05	8.05e-05	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—prostate cancer	5.98e-05	8.04e-05	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—prostate cancer	5.98e-05	8.03e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Capecitabine—prostate cancer	5.96e-05	8.01e-05	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—prostate cancer	5.96e-05	8.01e-05	CcSEcCtD
Gabapentin—Body temperature increased—Docetaxel—prostate cancer	5.95e-05	8e-05	CcSEcCtD
Gabapentin—Abdominal pain—Docetaxel—prostate cancer	5.95e-05	8e-05	CcSEcCtD
Gabapentin—Chills—Doxorubicin—prostate cancer	5.94e-05	7.98e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—prostate cancer	5.92e-05	0.000306	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Prednisone—prostate cancer	5.92e-05	7.95e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CAV1—prostate cancer	5.88e-05	0.000303	CbGpPWpGaD
Gabapentin—Insomnia—Prednisone—prostate cancer	5.87e-05	7.89e-05	CcSEcCtD
Gabapentin—Vision blurred—Epirubicin—prostate cancer	5.87e-05	7.88e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PARP1—prostate cancer	5.85e-05	0.000302	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGFR4—prostate cancer	5.85e-05	0.000302	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—prostate cancer	5.85e-05	0.000302	CbGpPWpGaD
Gabapentin—Alopecia—Doxorubicin—prostate cancer	5.85e-05	7.85e-05	CcSEcCtD
Gabapentin—Paraesthesia—Prednisone—prostate cancer	5.83e-05	7.84e-05	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—prostate cancer	5.8e-05	7.79e-05	CcSEcCtD
Gabapentin—Urticaria—Capecitabine—prostate cancer	5.79e-05	7.78e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CALCA—prostate cancer	5.78e-05	0.000298	CbGpPWpGaD
Gabapentin—Ill-defined disorder—Epirubicin—prostate cancer	5.77e-05	7.76e-05	CcSEcCtD
Gabapentin—Abdominal pain—Capecitabine—prostate cancer	5.76e-05	7.74e-05	CcSEcCtD
Gabapentin—Body temperature increased—Capecitabine—prostate cancer	5.76e-05	7.74e-05	CcSEcCtD
Gabapentin—Vomiting—Etoposide—prostate cancer	5.76e-05	7.74e-05	CcSEcCtD
Gabapentin—Erythema—Doxorubicin—prostate cancer	5.76e-05	7.74e-05	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—prostate cancer	5.76e-05	7.74e-05	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—prostate cancer	5.75e-05	7.73e-05	CcSEcCtD
Gabapentin—Agitation—Epirubicin—prostate cancer	5.72e-05	7.69e-05	CcSEcCtD
Gabapentin—Dyspepsia—Prednisone—prostate cancer	5.72e-05	7.68e-05	CcSEcCtD
Gabapentin—Rash—Etoposide—prostate cancer	5.71e-05	7.68e-05	CcSEcCtD
Gabapentin—Dermatitis—Etoposide—prostate cancer	5.71e-05	7.67e-05	CcSEcCtD
Gabapentin—Headache—Etoposide—prostate cancer	5.68e-05	7.63e-05	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—prostate cancer	5.67e-05	7.62e-05	CcSEcCtD
Gabapentin—Tension—Doxorubicin—prostate cancer	5.65e-05	7.59e-05	CcSEcCtD
Gabapentin—Decreased appetite—Prednisone—prostate cancer	5.65e-05	7.59e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CXCL12—prostate cancer	5.64e-05	0.000291	CbGpPWpGaD
Gabapentin—Dysgeusia—Doxorubicin—prostate cancer	5.64e-05	7.58e-05	CcSEcCtD
Gabapentin—Malaise—Epirubicin—prostate cancer	5.61e-05	7.54e-05	CcSEcCtD
Gabapentin—Fatigue—Prednisone—prostate cancer	5.6e-05	7.52e-05	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—prostate cancer	5.59e-05	7.52e-05	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—prostate cancer	5.59e-05	7.51e-05	CcSEcCtD
Gabapentin—Syncope—Epirubicin—prostate cancer	5.58e-05	7.5e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—EP300—prostate cancer	5.58e-05	0.000288	CbGpPWpGaD
Gabapentin—Leukopenia—Epirubicin—prostate cancer	5.57e-05	7.49e-05	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—prostate cancer	5.57e-05	7.48e-05	CcSEcCtD
Gabapentin—Constipation—Prednisone—prostate cancer	5.55e-05	7.46e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Docetaxel—prostate cancer	5.55e-05	7.46e-05	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—prostate cancer	5.54e-05	7.44e-05	CcSEcCtD
Gabapentin—Palpitations—Epirubicin—prostate cancer	5.5e-05	7.39e-05	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—prostate cancer	5.47e-05	7.35e-05	CcSEcCtD
Gabapentin—Cough—Epirubicin—prostate cancer	5.43e-05	7.3e-05	CcSEcCtD
Gabapentin—Vision blurred—Doxorubicin—prostate cancer	5.43e-05	7.29e-05	CcSEcCtD
Gabapentin—Asthenia—Docetaxel—prostate cancer	5.4e-05	7.26e-05	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—prostate cancer	5.39e-05	7.25e-05	CcSEcCtD
Gabapentin—Nausea—Etoposide—prostate cancer	5.38e-05	7.23e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—prostate cancer	5.38e-05	0.000278	CbGpPWpGaD
Gabapentin—Hypertension—Epirubicin—prostate cancer	5.37e-05	7.22e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Capecitabine—prostate cancer	5.37e-05	7.22e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—prostate cancer	5.35e-05	0.000276	CbGpPWpGaD
Gabapentin—Feeling abnormal—Prednisone—prostate cancer	5.35e-05	7.19e-05	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—prostate cancer	5.34e-05	7.18e-05	CcSEcCtD
Gabapentin—Pruritus—Docetaxel—prostate cancer	5.33e-05	7.16e-05	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—prostate cancer	5.32e-05	7.15e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CASP9—prostate cancer	5.32e-05	0.000274	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Prednisone—prostate cancer	5.31e-05	7.14e-05	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—prostate cancer	5.3e-05	7.12e-05	CcSEcCtD
Gabapentin—Myalgia—Epirubicin—prostate cancer	5.3e-05	7.12e-05	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—prostate cancer	5.3e-05	7.12e-05	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—prostate cancer	5.29e-05	7.11e-05	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—prostate cancer	5.28e-05	7.1e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.26e-05	7.07e-05	CcSEcCtD
Gabapentin—Discomfort—Epirubicin—prostate cancer	5.24e-05	7.03e-05	CcSEcCtD
Gabapentin—Asthenia—Capecitabine—prostate cancer	5.23e-05	7.03e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—prostate cancer	5.2e-05	0.000269	CbGpPWpGaD
Gabapentin—Malaise—Doxorubicin—prostate cancer	5.19e-05	6.98e-05	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—prostate cancer	5.18e-05	6.96e-05	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—prostate cancer	5.17e-05	6.95e-05	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—prostate cancer	5.16e-05	6.94e-05	CcSEcCtD
Gabapentin—Urticaria—Prednisone—prostate cancer	5.16e-05	6.93e-05	CcSEcCtD
Gabapentin—Pruritus—Capecitabine—prostate cancer	5.16e-05	6.93e-05	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—prostate cancer	5.16e-05	6.93e-05	CcSEcCtD
Gabapentin—Diarrhoea—Docetaxel—prostate cancer	5.15e-05	6.92e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PRKCQ—prostate cancer	5.15e-05	0.000266	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NGFR—prostate cancer	5.15e-05	0.000266	CbGpPWpGaD
Gabapentin—Body temperature increased—Prednisone—prostate cancer	5.13e-05	6.9e-05	CcSEcCtD
Gabapentin—Abdominal pain—Prednisone—prostate cancer	5.13e-05	6.9e-05	CcSEcCtD
Gabapentin—Confusional state—Epirubicin—prostate cancer	5.12e-05	6.88e-05	CcSEcCtD
Gabapentin—Palpitations—Doxorubicin—prostate cancer	5.09e-05	6.84e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MAP3K7—prostate cancer	5.09e-05	0.000263	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Epirubicin—prostate cancer	5.08e-05	6.83e-05	CcSEcCtD
Gabapentin—Oedema—Epirubicin—prostate cancer	5.08e-05	6.83e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—INS—prostate cancer	5.07e-05	0.000262	CbGpPWpGaD
Gabapentin—Loss of consciousness—Doxorubicin—prostate cancer	5.06e-05	6.8e-05	CcSEcCtD
Gabapentin—Infection—Epirubicin—prostate cancer	5.05e-05	6.78e-05	CcSEcCtD
Gabapentin—Cough—Doxorubicin—prostate cancer	5.03e-05	6.75e-05	CcSEcCtD
Gabapentin—Shock—Epirubicin—prostate cancer	5e-05	6.71e-05	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—prostate cancer	4.99e-05	6.7e-05	CcSEcCtD
Gabapentin—Diarrhoea—Capecitabine—prostate cancer	4.99e-05	6.7e-05	CcSEcCtD
Gabapentin—Nervous system disorder—Epirubicin—prostate cancer	4.98e-05	6.69e-05	CcSEcCtD
Gabapentin—Dizziness—Docetaxel—prostate cancer	4.98e-05	6.69e-05	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—prostate cancer	4.97e-05	6.68e-05	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—prostate cancer	4.97e-05	6.68e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CREBBP—prostate cancer	4.96e-05	0.000256	CbGpPWpGaD
Gabapentin—Tachycardia—Epirubicin—prostate cancer	4.96e-05	6.66e-05	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—prostate cancer	4.93e-05	6.63e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Epirubicin—prostate cancer	4.91e-05	6.6e-05	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—prostate cancer	4.9e-05	6.59e-05	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—prostate cancer	4.9e-05	6.59e-05	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—prostate cancer	4.9e-05	6.59e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGF10—prostate cancer	4.89e-05	0.000253	CbGpPWpGaD
Gabapentin—Anxiety—Doxorubicin—prostate cancer	4.89e-05	6.56e-05	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.87e-05	6.54e-05	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—prostate cancer	4.84e-05	6.51e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ADRB2—prostate cancer	4.84e-05	0.00025	CbGpPWpGaD
Gabapentin—Anorexia—Epirubicin—prostate cancer	4.84e-05	6.51e-05	CcSEcCtD
Gabapentin—Dizziness—Capecitabine—prostate cancer	4.82e-05	6.48e-05	CcSEcCtD
Gabapentin—Dry mouth—Doxorubicin—prostate cancer	4.8e-05	6.44e-05	CcSEcCtD
Gabapentin—Vomiting—Docetaxel—prostate cancer	4.79e-05	6.43e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Prednisone—prostate cancer	4.79e-05	6.43e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—JAK2—prostate cancer	4.78e-05	0.000247	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAP2K1—prostate cancer	4.76e-05	0.000246	CbGpPWpGaD
Gabapentin—Rash—Docetaxel—prostate cancer	4.75e-05	6.38e-05	CcSEcCtD
Gabapentin—Hypotension—Epirubicin—prostate cancer	4.75e-05	6.38e-05	CcSEcCtD
Gabapentin—Dermatitis—Docetaxel—prostate cancer	4.74e-05	6.37e-05	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—prostate cancer	4.74e-05	6.37e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—prostate cancer	4.73e-05	0.000244	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VAV3—prostate cancer	4.72e-05	0.000244	CbGpPWpGaD
Gabapentin—Headache—Docetaxel—prostate cancer	4.72e-05	6.34e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—prostate cancer	4.71e-05	0.000243	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Doxorubicin—prostate cancer	4.7e-05	6.32e-05	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—prostate cancer	4.7e-05	6.32e-05	CcSEcCtD
Gabapentin—Infection—Doxorubicin—prostate cancer	4.67e-05	6.27e-05	CcSEcCtD
Gabapentin—Asthenia—Prednisone—prostate cancer	4.66e-05	6.26e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TGFBR2—prostate cancer	4.65e-05	0.00024	CbGpPWpGaD
Gabapentin—Vomiting—Capecitabine—prostate cancer	4.64e-05	6.23e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.63e-05	6.22e-05	CcSEcCtD
Gabapentin—Shock—Doxorubicin—prostate cancer	4.62e-05	6.21e-05	CcSEcCtD
Gabapentin—Nervous system disorder—Doxorubicin—prostate cancer	4.61e-05	6.19e-05	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—prostate cancer	4.6e-05	6.18e-05	CcSEcCtD
Gabapentin—Rash—Capecitabine—prostate cancer	4.6e-05	6.18e-05	CcSEcCtD
Gabapentin—Pruritus—Prednisone—prostate cancer	4.6e-05	6.17e-05	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—prostate cancer	4.59e-05	6.17e-05	CcSEcCtD
Gabapentin—Dermatitis—Capecitabine—prostate cancer	4.59e-05	6.17e-05	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—prostate cancer	4.59e-05	6.16e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ITPR1—prostate cancer	4.58e-05	0.000236	CbGpPWpGaD
Gabapentin—Headache—Capecitabine—prostate cancer	4.57e-05	6.14e-05	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—prostate cancer	4.57e-05	6.13e-05	CcSEcCtD
Gabapentin—Paraesthesia—Epirubicin—prostate cancer	4.56e-05	6.13e-05	CcSEcCtD
Gabapentin—Hyperhidrosis—Doxorubicin—prostate cancer	4.54e-05	6.1e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—prostate cancer	4.54e-05	0.000234	CbGpPWpGaD
Gabapentin—Dyspnoea—Epirubicin—prostate cancer	4.53e-05	6.08e-05	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—prostate cancer	4.52e-05	6.07e-05	CcSEcCtD
Gabapentin—Anorexia—Doxorubicin—prostate cancer	4.48e-05	6.02e-05	CcSEcCtD
Gabapentin—Nausea—Docetaxel—prostate cancer	4.47e-05	6.01e-05	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—prostate cancer	4.47e-05	6.01e-05	CcSEcCtD
Gabapentin—Diarrhoea—Prednisone—prostate cancer	4.44e-05	5.97e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—NOS3—prostate cancer	4.44e-05	0.000229	CbGpPWpGaD
Gabapentin—Decreased appetite—Epirubicin—prostate cancer	4.42e-05	5.93e-05	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—prostate cancer	4.39e-05	5.9e-05	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Epirubicin—prostate cancer	4.39e-05	5.89e-05	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—prostate cancer	4.38e-05	5.88e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—IGF1R—prostate cancer	4.38e-05	0.000226	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—prostate cancer	4.36e-05	0.000225	CbGpPWpGaD
Gabapentin—Pain—Epirubicin—prostate cancer	4.34e-05	5.84e-05	CcSEcCtD
Gabapentin—Constipation—Epirubicin—prostate cancer	4.34e-05	5.84e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—JAK2—prostate cancer	4.34e-05	0.000224	CbGpPWpGaD
Gabapentin—Nausea—Capecitabine—prostate cancer	4.33e-05	5.82e-05	CcSEcCtD
Gabapentin—Dizziness—Prednisone—prostate cancer	4.29e-05	5.77e-05	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.28e-05	5.75e-05	CcSEcCtD
Gabapentin—Insomnia—Doxorubicin—prostate cancer	4.25e-05	5.71e-05	CcSEcCtD
Gabapentin—Paraesthesia—Doxorubicin—prostate cancer	4.22e-05	5.67e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—LPL—prostate cancer	4.2e-05	0.000217	CbGpPWpGaD
Gabapentin—Dyspnoea—Doxorubicin—prostate cancer	4.19e-05	5.63e-05	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—prostate cancer	4.19e-05	5.62e-05	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—prostate cancer	4.18e-05	5.61e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—IL2—prostate cancer	4.17e-05	0.000215	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFRB—prostate cancer	4.16e-05	0.000215	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Epirubicin—prostate cancer	4.15e-05	5.58e-05	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—prostate cancer	4.14e-05	5.56e-05	CcSEcCtD
Gabapentin—Vomiting—Prednisone—prostate cancer	4.13e-05	5.55e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PIK3CA—prostate cancer	4.13e-05	0.000213	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—prostate cancer	4.12e-05	0.000213	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—prostate cancer	4.1e-05	0.000212	CbGpPWpGaD
Gabapentin—Rash—Prednisone—prostate cancer	4.1e-05	5.5e-05	CcSEcCtD
Gabapentin—Dermatitis—Prednisone—prostate cancer	4.09e-05	5.5e-05	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—prostate cancer	4.09e-05	5.49e-05	CcSEcCtD
Gabapentin—Headache—Prednisone—prostate cancer	4.07e-05	5.47e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PTGS2—prostate cancer	4.06e-05	0.00021	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.06e-05	5.45e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ITGB3—prostate cancer	4.05e-05	0.000209	CbGpPWpGaD
Gabapentin—Fatigue—Doxorubicin—prostate cancer	4.05e-05	5.44e-05	CcSEcCtD
Gabapentin—Urticaria—Epirubicin—prostate cancer	4.04e-05	5.42e-05	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—prostate cancer	4.02e-05	5.4e-05	CcSEcCtD
Gabapentin—Pain—Doxorubicin—prostate cancer	4.02e-05	5.4e-05	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—prostate cancer	4.02e-05	5.4e-05	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—prostate cancer	4.02e-05	5.4e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—prostate cancer	3.96e-05	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB3—prostate cancer	3.93e-05	0.000203	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGFR2—prostate cancer	3.93e-05	0.000203	CbGpPWpGaD
Gabapentin—Feeling abnormal—Doxorubicin—prostate cancer	3.87e-05	5.2e-05	CcSEcCtD
Gabapentin—Nausea—Prednisone—prostate cancer	3.86e-05	5.18e-05	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—prostate cancer	3.84e-05	5.16e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IL2—prostate cancer	3.78e-05	0.000195	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—prostate cancer	3.77e-05	0.000195	CbGpPWpGaD
Gabapentin—Hypersensitivity—Epirubicin—prostate cancer	3.74e-05	5.03e-05	CcSEcCtD
Gabapentin—Urticaria—Doxorubicin—prostate cancer	3.73e-05	5.02e-05	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—prostate cancer	3.72e-05	4.99e-05	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—prostate cancer	3.72e-05	4.99e-05	CcSEcCtD
Gabapentin—Asthenia—Epirubicin—prostate cancer	3.64e-05	4.9e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—prostate cancer	3.61e-05	0.000186	CbGpPWpGaD
Gabapentin—Pruritus—Epirubicin—prostate cancer	3.59e-05	4.83e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PTEN—prostate cancer	3.54e-05	0.000183	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—prostate cancer	3.52e-05	0.000182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CAV1—prostate cancer	3.49e-05	0.00018	CbGpPWpGaD
Gabapentin—Diarrhoea—Epirubicin—prostate cancer	3.48e-05	4.67e-05	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—prostate cancer	3.46e-05	4.65e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—KDR—prostate cancer	3.45e-05	0.000178	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—EP300—prostate cancer	3.38e-05	0.000175	CbGpPWpGaD
Gabapentin—Asthenia—Doxorubicin—prostate cancer	3.37e-05	4.53e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—AKT1—prostate cancer	3.37e-05	0.000174	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—prostate cancer	3.36e-05	0.000173	CbGpPWpGaD
Gabapentin—Dizziness—Epirubicin—prostate cancer	3.36e-05	4.51e-05	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—prostate cancer	3.33e-05	4.47e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—BAD—prostate cancer	3.28e-05	0.000169	CbGpPWpGaD
Gabapentin—Vomiting—Epirubicin—prostate cancer	3.23e-05	4.34e-05	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—prostate cancer	3.22e-05	4.32e-05	CcSEcCtD
Gabapentin—Rash—Epirubicin—prostate cancer	3.2e-05	4.3e-05	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—prostate cancer	3.2e-05	4.3e-05	CcSEcCtD
Gabapentin—Headache—Epirubicin—prostate cancer	3.18e-05	4.28e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—APC—prostate cancer	3.18e-05	0.000164	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—prostate cancer	3.18e-05	0.000164	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGF—prostate cancer	3.14e-05	0.000162	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS1—prostate cancer	3.14e-05	0.000162	CbGpPWpGaD
Gabapentin—Dizziness—Doxorubicin—prostate cancer	3.11e-05	4.18e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GSK3B—prostate cancer	3.05e-05	0.000157	CbGpPWpGaD
Gabapentin—Nausea—Epirubicin—prostate cancer	3.02e-05	4.05e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—INS—prostate cancer	3.01e-05	0.000155	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—prostate cancer	2.99e-05	4.02e-05	CcSEcCtD
Gabapentin—Rash—Doxorubicin—prostate cancer	2.96e-05	3.98e-05	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—prostate cancer	2.96e-05	3.98e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CREBBP—prostate cancer	2.94e-05	0.000152	CbGpPWpGaD
Gabapentin—Headache—Doxorubicin—prostate cancer	2.94e-05	3.96e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—IGF1—prostate cancer	2.91e-05	0.00015	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—prostate cancer	2.89e-05	0.000149	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAP2K1—prostate cancer	2.81e-05	0.000145	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—prostate cancer	2.79e-05	0.000144	CbGpPWpGaD
Gabapentin—Nausea—Doxorubicin—prostate cancer	2.79e-05	3.75e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—prostate cancer	2.77e-05	0.000143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—prostate cancer	2.76e-05	0.000143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—prostate cancer	2.73e-05	0.000141	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF2—prostate cancer	2.67e-05	0.000138	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—prostate cancer	2.64e-05	0.000136	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAK2—prostate cancer	2.56e-05	0.000132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—prostate cancer	2.51e-05	0.00013	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MDM2—prostate cancer	2.5e-05	0.000129	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—prostate cancer	2.5e-05	0.000129	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB2—prostate cancer	2.47e-05	0.000127	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—prostate cancer	2.43e-05	0.000126	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—prostate cancer	2.34e-05	0.000121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1B—prostate cancer	2.28e-05	0.000118	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—prostate cancer	2.26e-05	0.000117	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—prostate cancer	2.24e-05	0.000116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL2—prostate cancer	2.24e-05	0.000115	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—prostate cancer	2.22e-05	0.000115	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—prostate cancer	2.18e-05	0.000112	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNB1—prostate cancer	2.16e-05	0.000111	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—prostate cancer	2.12e-05	0.000109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN1A—prostate cancer	2.11e-05	0.000109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—prostate cancer	2.1e-05	0.000109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—prostate cancer	2.05e-05	0.000106	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—prostate cancer	2.04e-05	0.000105	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EP300—prostate cancer	2.01e-05	0.000104	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SRC—prostate cancer	1.95e-05	0.000101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—prostate cancer	1.9e-05	9.81e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—prostate cancer	1.88e-05	9.71e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—prostate cancer	1.75e-05	9.02e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—prostate cancer	1.74e-05	9e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—prostate cancer	1.71e-05	8.83e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—prostate cancer	1.61e-05	8.34e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—prostate cancer	1.48e-05	7.66e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—prostate cancer	1.44e-05	7.41e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—prostate cancer	1.31e-05	6.78e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—prostate cancer	1.21e-05	6.26e-05	CbGpPWpGaD
